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The capsular components of the human pathogen Cryptococcus neoformans are transported to the extracel-
lular space and then used for capsule enlargement by distal growth. It is not clear, however, how the
glucuronoxylomannan (GXM) fibers are incorporated into the capsule. In the present study, we show that
concentration of C. neoformans culture supernatants by ultrafiltration results in the formation of highly viscous
films containing pure polysaccharide, providing a novel, nondenaturing, and extremely rapid method to isolate
extracellular GXM. The weight-averaged molecular mass of GXM in the film, determined using multiangle
laser light scattering, was ninefold smaller than that of GXM purified from culture supernatants by differential
precipitation with cetyl trimethyl ammonium bromide (CTAB). Polysaccharides obtained either by ultrafil-
tration or by CTAB-mediated precipitation showed different reactivities with GXM-specific monoclonal anti-
bodies. Viscosity analysis associated with inductively coupled plasma mass spectrometry and measurements of
zeta potential in the presence of different ions implied that polysaccharide aggregation was a consequence of
the interaction between the carboxyl groups of glucuronic acid and divalent cations. Consistent with this
observation, capsule enlargement in living C. neoformans cells was influenced by Ca2 in the culture medium.
These results suggest that capsular assembly in C. neoformans results from divalent cation-mediated self-
aggregation of extracellularly accumulated GXM molecules.
Cryptococcus neoformans is a widely distributed microorgan-
ism that is the etiologic agent for cryptococcosis, a pulmonary
and disseminated mycosis that affects primarily immunosup-
pressed patients (34). Cryptococcal meningitis and meningoen-
cephalitis may lead to permanent neurological damage, and the
mortality rate of patients suffering from cryptococcosis is 12%
(http://www.cdc.gov/ncidod/dbmd/diseaseinfo/cryptococcosis_t.htm).
Given the high morbidity and mortality associated with cryp-
tococcosis, therapy for this disease remains unsatisfactory, and
currently there are no vaccines available to prevent the disease.
C. neoformans is remarkable among eukaryotic pathogenic
microbes because of the presence of a polysaccharide capsule
composed of galactoxylomannan and glucuronoxylomannan
(GXM) (3, 21, 24). Galactoxylomannan has an average mass of
100 kDa, and its biological functions are only beginning to be
understood (28, 35). GXM, in contrast, is a 1,700- to 7,000-kDa
polysaccharide (28, 29) that comprises up to 90% of the cap-
sule’s mass. It consists of an -1,3-linked mannan main chain
with xylosyl and glucuronyl side chains (3, 21, 24). The man-
nose backbone of GXM is O acetylated, a modification that
can influence antibody binding and complement activation
(25). Although the biological and structural properties of
GXM have been extensively studied, the mechanism by which
this polysaccharide contributes to virulence remains poorly
understood. There is considerable evidence, however, that
GXM interferes with the host immune response by multiple
mechanisms (30). Antibodies to GXM are protective (5, 11, 12,
31, 32), and GXM antigens may constitute a potential vaccine
against cryptococcosis (9). Moreover, monoclonal antibodies
(MAbs) to GXM are in clinical development for patients with
cryptococcosis (26).
Recent studies demonstrate that the cryptococcal capsule
grows distally by the self-association of GXM fibers (28, 44),
but the mechanisms responsible for enlargement remain un-
clear. Early studies showed that alkaline conditions usually facil-
itate capsule growth (14, 15, 19, 39, 45), an observation consistent
with the view that capsule enlargement occurs when the acidic
groups of glucuronic acid (GlcA) residues are ionized. In addi-
tion, capsule growth is blocked when C. neoformans is cultivated
in the presence of high concentrations of sodium chloride (14,
20). Although changes in the ion concentrations of the medium
can be expected to have numerous effects on fungal metabolism,
these results could suggest that the protonation of the carboxyl
groups of GXM or salt formation with monovalent ions results in
inhibition of capsule growth.
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In the present study, we report that concentration by ultra-
filtration of cell-free culture supernatant fluids of C. neofor-
mans results in the formation of a dense, jellified layer on the
filter disc. Chemical, structural, and serological analyses of this
viscous film revealed that it consisted of essentially pure GXM,
yet it differed in certain physical and immunological properties
from GXM prepared by classical precipitation methods. Vis-
cosity analysis suggested that calcium bridges are responsible
for the high density of the GXM-containing film. Based on
these results, we propose that polysaccharide cross-linking by
divalent metals could lead to GXM self-aggregation on the
surface of C. neoformans and that this process contributes to
capsule assembly.
MATERIALS AND METHODS
GXM purification. C. neoformans strain ATCC 24067 (serotype D; American
Type Culture Collection) was used in all experiments of the current study. C.
neoformans cells (109) were inoculated into 1,000-ml Erlenmeyer flasks contain-
ing 400 ml of minimal medium composed of glucose (15 mM), MgSO4 (10 mM),
KH2PO4 (29.4 mM), glycine (13 mM), and thiamine-HCl (3 M), pH 5.5. Fungal
cells were cultivated for 3 days at 30°C with shaking and separated from culture
supernatants by centrifugation at 4,000  g (15 min, 4°C). The supernatant fluids
were collected and centrifuged again at 15,000  g (15 min, 4°C) to remove
smaller debris. The pellets were discarded, and the resulting supernatant was
concentrated approximately 20-fold using an Amicon (Millipore, Danvers, MA)
ultrafiltration cell (with a cutoff of 100 kDa and a total capacity of 200 ml) with
stirring and Biomax polyethersulfone ultrafiltration discs (63.5 mm) (see Fig. S1
in the supplemental material). A nitrogen (N2) stream was used as the pressure
gas. After the supernatant was concentrated, a thick, translucent film was ob-
served in close association with the ultrafiltration disc and was covered by a
concentrated fluid phase. The fluid phase was discarded, and the viscous layer
was collected with a cell scraper for storage at room temperature. Fractions that
were passed through the 100-kDa filtration discs were filtered through 10-kDa
membranes, resulting again in film formation. For polysaccharide quantification,
a capture enzyme-linked immunosorbent assay (ELISA) (4), the carbazole re-
action for hexuronic acid (10), and the method for hexose detection described by
Dubois et al. (13) were used.
NMR analysis. 1H nuclear magnetic resonance (NMR) spectra of de-O-acety-
lated polysaccharides were recorded using a Bruker DRX 600 apparatus with a
triple-resonance probe. The removal of O-acetyl groups was performed by dis-
solving 5 mg of GXM in 1 ml of H2O, followed by adjustment of the pH to 11.25
with NH4OH. The resulting solution was stirred for 24 h at 23°C and dialyzed
against water (6). Spectra of a de-O-acetylated GXM solution (5 mg in 0.5 ml of
99.9% D2O; Cambridge Isotope Laboratory) were recorded at 70°C with HOD
suppression by presaturation. Homonuclear total correlation spectroscopy
(TOCSY) spectra were recorded using states-time proportion phase incremen-
tation for quadrature detection in the indirect dimension. TOCSY spectra were
run with 4,096 by 256 points with a spin-lock field of 10 kHz and a mixing time
of 80 ms. Chemical shifts are relative to external trimethylsilylpropionic acid at
0 ppm for 1H. Results obtained in the current analysis were compared with
previously described GXM spectral data (1, 2, 6–8).
Monosaccharide analysis. Sugar composition was determined by gas chroma-
tography-mass spectrometry (GC-MS) analysis of the per-O-trimethylsilyl
(TMS)-derivatized monosaccharides from the polysaccharide film. Methyl gly-
cosides were first prepared from the dry sample (0.3 mg) by methanolysis in
methanol-1 M HCl at 80°C (18 to 22 h). The sample was then per-O-trimethyl-
silylated by treatment with Tri-Sil (Pierce) at 80°C (0.5 h). GC-MS analysis of the
per-O-TMS derivatives was performed on a model HP 5890 GC interfaced with
a model 5970 MSD MS, using a Supelco DB-1 fused-silica capillary column (30
m by 0.25 mm [inside diameter]). The carbohydrate standards used were arabi-
nose, rhamnose, fucose, xylose, glucuronic acid, galacturonic acid, mannose,
galactose, glucose, mannitol, dulcitol, and sorbitol.
Binding of divalent metals to GXM. The jellified GXM (2 mg) was diluted to
a final volume of 3 ml in 10 mM EDTA and then distributed in dialysis cassettes
(molecular mass cutoff, 10 kDa). The GXM-EDTA solution was dialyzed against
1 mM EDTA for 24 h and then against water for 24 h. The resulting solution,
considered cation-free GXM, was supplemented with chloride salts of Ca2 or
Mg2 to final concentrations ranging from 0 to 10 mM and incubated for 1 h at
room temperature. Unbound cations were then removed from the system by ultra-
filtration in Millipore concentration tubes (molecular mass cutoff, 100 kDa). The
presence of Ca2 or Mg2 in association with the polysaccharide was measured by
inductively coupled plasma MS (Quantitative Technologies, Inc., Whitehouse, NJ).
A Perkin-Elmer Elan inductively coupled plasma MS was used for metal detection.
The elemental content in each sample was determined after comparison with pre-
viously constructed calibration curves using cation standards.
Effects of cation binding on the cellular charge of C. neoformans. Yeast cells
were washed three times with distilled, deionized water and resuspended in 10
mM EDTA. The cell suspension was then dialyzed against 1 mM EDTA for 12 h,
with replacement of the chelating solutions by fresh ones after 2-h intervals. The
cell suspension was then dialyzed against water by following the same protocol.
C. neoformans cells were centrifuged and suspended in different solutions of
chloride salts of Ca2 and Mg2 and incubated for 2 h. After the removal of
unbound ions by washing the cells, zeta potential () measurements of cellular
charge were made using the ZetaPlus zeta potential analyzer (Brookhaven In-
struments, Holtsville, NY).  is defined as the potential gradient that develops
across the interface between a boundary liquid in contact with a solid and the
mobile diffuse layer in the body of the liquid. It is derived from the equation  
(4	m)/D, where D is the dielectric constant of the medium, 	 is the viscosity,
and m is the electrophoretic mobility of the particle.
Viscosity determinations. The characterization of the Brownian motion of
polystyrene spheres (radius, 1.52 
 0.05 m) immersed in GXM solutions was
the parameter used to measure viscosity (40). A water suspension of the spheres
(1 l, 10% [vol/vol]) was dispersed in 150 l of an extensively dialyzed 0.75-
mg/ml solution of GXM. This mixture was placed onto a coverslip with an O ring
with a 1-cm diameter and a 0.3-cm width. Alternatively, the GXM solution was
supplemented with various concentrations of NaCl (0.01 to 1,000 mM), CaCl2
(0.0001 to 10 mM), or EDTA (0.0001 to 10 mM), or the intact polysaccharide
preparation was replaced by an equivalent solution of carboxyl-reduced GXM,
prepared according to the method of Taylor and Conrad (38). The O ring was
covered with another coverslip to avoid evaporation. The sample was then
transferred to an inverted Nikon Eclipse TE300 microscope connected by its
epifluorescence port to a neodymium-doped yttrium aluminum garnet laser
beam source (with a 1,064-nm wavelength). When the laser beam passes through
the objective, it creates an optical trap near the objective focus, allowing the
manipulation of small dielectric objects (in order of length measured in mi-
crometers). The microscope was mounted on a Newport table stabilized to avoid
vibrations from the environment. The samples were observed with a Plan Apo
100 NA1.4 objective. Digitized images were obtained by a charged-couple-
device camera connected to Hamamatsu Argus and Scion frame grabbers. Im-
ages were processed using the ImageJ software, elaborated and provided by the
National Institutes of Health (http://rsb.info.nih.gov/ij/). The reference distance
(height, h  a, where h is the distance from the sphere center to the coverslip and
a is the bead radius) between the bottom of the coverslip and each sphere was
determined by trapping the sphere using the optical tweezers and then moving it
towards the coverslip using the microscope knob. After positioning the bead at
the desired height, a small image area (50 pixels by 50 pixels) was chosen for
frame rate capture (27 to 28 frames per second). The optical tweezers were then
alternately turned on and off for periods of 0.5 s by shutting the beam (41).
The mean square displacement of the variation of the image center of mass
position  in a time interval t is given by:
2 4Dt (1)
where
D
kBT

(2)
and , the Stokes friction coefficient, is a function of the bead radius a and the
height h.  is given by the Faxen Law (16):
 6	a1 916ah  18ah
3

45
256ah
4

1
16ah
51 (3)
For a fixed value of h, ()2 was calculated, excluding the regions where  was
0.01 m. Those regions correspond to the time intervals for which the bead was
trapped. From the linear fit of the measured ()2 values as a function of time
t in equation 1, the diffusion coefficient D was obtained. With the value of D, the
Stokes friction coefficient  was determined using equation 2. The sphere height
was then changed and the procedure repeated. From the fit of the  values as
a function of sphere height h using equation 3, viscosity values were obtained.
The described method had 10 to 20% uncertainty for the viscosity determi-
nations.
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Effects of exogenously added Ca2 on capsule expression and GXM concen-
tration in culture supernatants. Cryptococci were suspended in a minimal me-
dium similar to that previously described in the text except that MgSO4 was not
added. In this medium, containing glucose, KH2PO4, glycine, and thiamine-HCl
at the concentrations described above and which had a pH of 5.5, cryptococcal
growth was similar to that observed in the regular medium (data not shown).
After three consecutive passages (at 2-day intervals) into flasks containing the
same medium, C. neoformans (104 yeast cells) was suspended in 100 l of fresh
cation-free medium supplemented with CaCl2 or MgCl2 in concentrations rang-
ing from 0 to 20 mM. After 48 h of cultivation at room temperature in 96-well
plates, the cells were recovered by centrifugation for 10 min at 2,000  g and
fixed in 2% paraformaldehyde in phosphate-buffered saline (PBS). Supernatants
were saved for GXM determination by capture ELISA as previously described
(4). The concentration of GXM in culture supernatants obtained from the
different growth conditions was normalized to the number of cells in the culture
after each condition of stimulation, as measured in a Neubauer chamber. The
fixed cells were then washed with PBS, and after they were stained with India ink,
the capsule expression was examined microscopically. Capsule sizes, defined as
the distances between the outer surfaces of the cell walls and the outer borders
of the capsules, were measured by using ImageJ software. All experiments were
performed in triplicate sets, and the values were compared using Student’s t test.
Capsule experiments using dead C. neoformans cells. To exclude the possibility
that the effects of Ca2 and/or Mg2 on capsule expression were derived from
cation regulation of metabolic processes instead of polysaccharide aggregation,
the capsule was analyzed in the presence of EDTA and divalent cations using
dead cells. C. neoformans was killed by heating the cells to 56°C for 1 h, a
procedure that results in the killing of 100% of cells (not shown). The dead cells
(107) were then resuspended in 10 mM EDTA and incubated for 30 min at room
temperature, and the capsule sizes were measured as described above. To eval-
uate whether GXM aggregation and consequent capsule enlargement would
occur with dead cells, C. neoformans was first exposed to gamma radiation from
radioisotope 137Cs to remove external layers of the polysaccharide capsule (27).
Briefly, yeast cells (5  107) were washed three times and suspended in H2O to
be irradiated for 1 h using the Shepherd Mark I irradiator (JL Shepherd and
Associates, San Fernando, CA) at 1,388 rads/min. Polysaccharide release in the
supernatant was confirmed by ELISA and India ink staining of irradiated cells
(not shown). Irradiated C. neoformans cells were then heated as described above
and suspended in the divalent cation-free culture medium supplemented with
GXM at 100 g/ml. Calcium chloride was then added to final concentrations
ranging from 100 to 0.0001 mM. Yeast suspensions were incubated for 12 h at
30°C, extensively washed with water, and suspended in PBS-bovine serum albu-
min at 3  104 cells/ml. The reactivities of these cells with antibodies to GXM
were evaluated by capture ELISA as previously described (4). For this assay, it
was assumed that the content of cell-associated GXM was directly proportional
to its capture by, and reactivity with, antibodies to GXM. Relative values of
GXM expression were obtained by dividing the ELISA absorbance values after
incubation of the yeast cells with GXM by those obtained immediately after
irradiation, which are considered the basal levels of polysaccharide expression.
Molecular mass determination of GXM. Molecular masses were calculated by
multiangle laser light scattering by following the conditions described by McFadden
et al. (29). The polysaccharides obtained were diluted in sterile-filtered, de-
gassed, ultrapure water to the desired concentrations from a freshly made
5-mg/ml stock solution. GXM samples included preparations obtained by ultra-
filtration as well as by cetyl trimethyl ammonium bromide (CTAB) precipitation
(8). To evaluate whether stirring would have any effect on the molecular mass, a
1-mg/ml solution of CTAB-precipitated polysaccharide was stirred with a mag-
netic bar for 24 h for further measurement of molecular mass. The change in the
refractive index (dn/dc) of the samples was measured by differential refractom-
etry using a 620-nm laser source (BI-DNDC; Brookhaven Instruments Corp.,
Holtsville, NY) at 30°C. The molecular mass was determined at room temper-
ature by multiangle laser light scattering (using a BI-MwA analyzer; Brookhaven
Instruments Corp., Holtsville, NY) using a 675-nm laser source. Before the mass
measurements were taken, the system was calibrated against toluene and nor-
malized for Rayleigh scattering with 20-nm microspheres (Duke Scientific Corp.,
Palo Alto, CA). The weight-averaged mass (Mw) was calculated by the Zimm
equation (46), Kc/R()  1/(Mw)[P()]  2A2c, where K is the optical constant,
defined as the quotient of 42no2(dn/dc)2/NAo4, and R() is the excess Ray-
leigh factor, determined by comparing the sample and solvent values at angle ()
and concentration (c). P() is the particle scattering function, A2 is the second
virial coefficient, no is the refractive index of the solvent, NA is Avogadro’s
number, and o is the modal wavelength of the laser source. The dn/dc values
were adjusted according to the Cauchy equation, dn/dc  A  B/2, using a B
coefficient for aqueous solutions of 0.0022 m and wavelengths () in mi-
crometers to accommodate the longer wavelength of the molecular weight ana-
lyzer. Depolarization corrections were assumed to be negligible. All samples
were passed through an in-line 0.8-m syringe filter to eliminate large aggregates
and reduce extraneous sources of refracted or scattered light.
Binding of MAbs to GXM. Binding of MAbs to GXM obtained by precipita-
tion with CTAB (8) or by the current ultrafiltration methodology was evaluated
by ELISA (4) and dot blot analysis. For the ELISA, polysaccharide solutions at
5 nM, calculated from the data presented in Table 1, were used to coat the wells
of 96-well plates. GXM detection was performed using two immunoglobulin M
(IgM) MAbs, known as 12A1 and 21D2 (33), and an IgG1, known as 18B7 (5).
Reactions were developed after the incubation of the plates with alkaline phos-
phatase-conjugated goat anti-mouse IgM or IgG1 followed by the addition of
p-nitrophenyl phosphate and measured at 405 nm with a Multiscan MS (Lab-
system, Helsinki, Finland). For the dot blot analysis, 0.5 nmol GXM in 2 l water
was loaded onto nitrocellulose membranes. The membranes were allowed to dry
for 1 h at 37°C and then were blocked with PBS containing 1% bovine serum
albumin. Blocked membranes were incubated with the antibodies described
above at starting dilutions of 10 g/ml. After being washed extensively, mem-
branes were sequentially incubated with alkaline phosphatase-conjugated goat
anti-mouse IgM or IgG1 and p-nitrophenyl phosphate solutions. Reactions were
quantified by the transfer of the soluble, colored products to the wells of 96-well
plates and reading at 405 nm as described above.
RESULTS
Extracellular GXM aggregates to form a highly viscous film.
After the complete removal of cells and debris by centrifuga-
tion, C. neoformans supernatants (at initial volumes of 800 ml)
were concentrated in ultrafiltration cells. Final volumes of 40
ml were achieved, and the upper fluid phase was removed.
Sticky, translucent, 2- to 4-mm-thick films were obtained on
the surfaces of the ultrafiltration discs (see Movie S1 in the
supplemental material). Concentration rates of supernatants
from different cultures varied, but films were always formed
after 1 to 3 h of ultrafiltration. The viscous films were then
collected with a cell scrapper and stored at room temperature
for further analysis. The final volume of the viscous film prep-
aration obtained from 800-ml cultures ranged from 10 to 15 ml.
Interestingly, film formation was also observed when superna-
tant fractions that were passed through the 100-kDa mem-
brane were concentrated using 10-kDa filtering discs (data not
shown). Serotype A C. neoformans strains and Cryptococcus
gattii isolates (serotypes B and C) were used under the same
conditions, with similar results being obtained (data not
shown).
Based on the high concentrations of GXM in cryptococcal
supernatants and its known ability to self-aggregate (29), we
suspected that the viscous film observed in the concentration
system could contain capsular polysaccharide shed into the
culture medium during fungal growth. The concentration of
GXM in this material was 7.5 mg/ml as measured by capture
ELISA.
TABLE 1. Average molecular masses, radius of gyration (Rg)
values, and mass density (Mw/Rg) values of GXM
GXM derivation method Mw(g/mol) Rg (nm) Mw/Rg (10
3)
CTAB precipitationa
Standard conditions 2.2  106 88.6 24.83
With stirring 1.8  106 79.4 22.6
Ultrafiltration 2.4  105 141.0 1.74
a As described by Cherniak et al. (8). CTAB-derived GXM samples were
analyzed under standard conditions or after 24 h of stirring.
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After acidic methanolysis of the sample, monosaccharide
constituents were analyzed by GC (Fig. 1A). This analysis
allows the potential detection of four different peaks for each
sugar derivative, corresponding to the  and  forms of
furanose and pyranose rings. In association with MS analysis,
each peak could be precisely identified based on the profile of
the fragmentation observed. The fragmentation of TMS deriv-
atives of hexoses usually generates diagnostic peaks at m/z 217
and 214 (23). Pyranose rings give rise to a (m/z 204)/(m/z 217)
ratio of 1, whereas furanose rings show a ratio of 1.
Peaks with retention times corresponding to standard deriv-
atives of the typical GXM components mannose (Man), xylose
(Xyl), and GlcA were detected (Fig. 1A). Three Man peaks
were observed at retention times of 17.3 min (90%, relative
intensity), 18.2 min (8%, relative intensity), and 19.3 min (2%,
relative intensity). By MS, these peaks were identified, respec-
tively, as -pyranosyl, -pyranosyl, and furanosyl forms of
TMS-Man (22). The peaks with retention times of 13.3 min
(67%, relative intensity) and 13.8 min (33%, relative intensity)
were characterized as - and -pyranosyl forms of Xyl. Finally,
the minor peaks with retention times of 15.5, 20.8, and 21.0
min corresponded to the different anomers of the TMS deriv-
atives of GlcA. The profile of fragmentation of the major peak
of each sugar is shown in the inset to Fig. 1A.
Man was the major polysaccharide constituent (59.4% of the
molar mass), followed by Xyl (32.1%) and GlcA (8.5%). These
results strongly indicate that the film deposited on the filtration
disc consisted of GXM. Rhamnose, fucose, glucose, mannitol,
and galactose were not detected in the samples analyzed by GC-
MS. The high carbohydrate content together with the monosac-
charide analysis suggests that the film deposited on the filtration
disc was composed largely, if not exclusively, of GXM. This in-
formation was supported by the lack of protein detection by
colorimetric and electrophoretic methods (data not shown).
FIG. 1. Structural analysis of the cryptococcal polysaccharide isolated by ultrafiltration. (A) GC-MS analysis revealed peaks with retention
times similar to those observed using standards of the typical GXM components (Man, Xyl, and GlcA). The inset shows a fragmentation profile
of the most abundant peak for each sugar detected by MS. (B) 1H NMR spectrum of the de-O-acetylated molecule and, in the inset, the identified
polysaccharide components in the current analysis. (C) TOCSY spectrum of the de-O-deacetylated structure. Regions corresponding to the sugar
units shown in panel B were assigned as shown.
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The purity and fine structure of the polysaccharide were
further confirmed by NMR analysis. Based on previous reports
on the structure of GXM (2, 7), structural reporter groups and
branches have been identified. The reference structures were
the pentasaccharide and the hexasaccharide, shown in Fig. 1B
and 1C, described as the most frequent repeating units in
isolate B-3501, a serotype D strain, and in Cap70, a capsule-
deficient mutant of this strain (2). The one-dimensional 1H
spectrum of the de-O-acetylated polysaccharide had signals at
5.21 ppm, assigned to Man H-1 (residue A), and 5.15 ppm,
representing the combined H-l chemical shifts of Man residues
B and C. The peaks observed at 4.45 and 4.35 ppm were
assigned to H-1 resonances of GlcA and Xyl (residue I), re-
spectively. The signal detected at 4.25 ppm corresponds to H-1
of Xyl II. These chemical shifts are all characteristic of sero-
type D GXM (2, 7). The double-quantum-filtered TOCSY
spectrum was interpreted using the information obtained in
the 1H spectrum and from previous studies (1, 2, 6–8). The
chemical shifts of the cross peaks labeled in Fig. 1C are con-
sistent with those H-1 assignments observed for the three man-
nosyl residues (A, B, and C), GlcA residues, and Xyl residues
(I and II). Complete chemical shift assignments for Man, Xyl,
and GlcA residues of the presently analyzed polysaccharide
were compared with those described previously for GXMs (1,
2, 6–8), confirming that the currently characterized molecule
represents the serotype D polysaccharide.
GXM aggregation is mediated by divalent ions. Anionic
polysaccharide chains can cross-link through bridges formed by
the interaction of divalent ions with the anionic sugar units
(42). We therefore hypothesized that the formation of GXM
aggregates after supernatant filtration depended on the inter-
action of negatively charged GlcA residues and divalent met-
als, which are abundant in the culture medium as Mg2 salts.
Our premise was that two GlcA residues from different GXM
chains could interact with one atom of the divalent ion, gen-
erating cross-linked polysaccharide chains. In this case, the
formation of cross-linkages would not take place if negative
charges were not abundant or if monovalent ions as well as
chelators of divalent cations were present in high concentra-
tions.
First, we analyzed the ability of GXM to bind to the divalent
cations Mg2 and Ca2. A cation-free solution of the GXM
film was incubated in the presence of various concentrations of
Ca2 and Mg2 chloride salts. As demonstrated in Fig. 2A, a
dose-dependent binding of these metals to the polysaccharide
was observed. Metal binding to surface-associated GXM was
observed using intact C. neoformans cells (Fig. 2B). A dose-
dependent decrease of cellular charge was observed when C.
neoformans was treated with chloride salts of Mg2 and Ca2,
supporting the hypothesis that divalent metals bind to the
negatively charged polysaccharide.
The results depicted in Fig. 2 were in agreement with the
hypothesis that, as demonstrated with plant polysaccharides
(42), the high viscosity observed with the GXM film is a con-
sequence of the interaction of negatively charged GlcA units in
the GXM with divalent cations. Consequently, we analyzed the
influence of the negative charges of GlcA on the viscosity of
the thick material obtained by ultrafiltration. After the car-
boxyl reduction of the polysaccharide, approximately 95% of
the total content of GlcA was converted to glucose, as deter-
mined spectrophotometrically. The viscosity of the reduced
polysaccharide solution fell to approximately 10% of that of
the native GXM film (Fig. 3A). This result implied that the
presence of the negative charges in the GlcA residues was
necessary for polysaccharide aggregation.
We therefore analyzed the influence of different concentra-
tions of Na and EDTA on the viscosity of the GXM film
obtained by ultrafiltration. Na caused a dose-dependent de-
crease in the viscosity of a polysaccharide solution at 0.75
mg/ml, as shown in Fig. 3B. Similar results were observed when
the polysaccharide was treated with EDTA (Fig. 3C). Signifi-
cant differences (P  0.01, Student’s t test) were observed
between viscosity values obtained in the absence of Na or
EDTA and those obtained after incubation of the polysaccha-
ride with the highest concentration of each compound. We
then evaluated whether the viscosity of GXM would be af-
fected by treatment with CaCl2. The results shown in Fig. 3D
demonstrate that Ca2 concentrations lower than 0.1 mM
were associated with increased polysaccharide viscosity.
Higher concentrations, however, resulted in decreased levels
of viscosity, indicating that the stoichiometry of the association
between Ca2 and GlcA residues shifted from the bridge-
forming ratio of 1:2 to 1:1, with a subsequent decrease in the
efficacy of association between different GXM fibers. Based on
the results obtained with the GC-MS analysis, the concentra-
tion of GlcA in the 0.75-mg/ml solution of GXM was estimated
to be approximately 0.4 mM. Consequently, Ca2 concentra-
FIG. 2. Ca2 and Mg2 binds to GXM and affects cellular charge.
(A) A cation-free preparation of GXM was treated with various con-
centrations of the divalent ions, and after the removal of unbound
elements, the Ca2 and Mg2 content was determined. A dose-depen-
dent profile of binding to GXM was observed for each metal. (B) After
the removal of divalent ions by treatment with EDTA and extensive
dialysis, the cellular charge of C. neoformans was measured in a zeta
potential analyzer. An inverse relationship between negative charge
and metal binding was observed.
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tions higher than 0.2 mM should exceed the 1:2 Ca2/GlcA
molar ratio. In fact, Ca2 concentrations in the range of 1 to 10
mM caused a marked decrease in polysaccharide viscosity.
These results indicate that the availability of Ca2 can regulate
GXM aggregation. When Ca2 was replaced by Mg2, similar
results were obtained (data not shown).
Capsule growth is influenced by divalent metals. The results
shown in Fig. 2 and 3 led us to investigate whether divalent
cations would influence capsule enlargement in C. neoformans.
Different assays using EDTA to chelate ions or divalent cations
to regulate capsule expression were performed. Ca2 and
Mg2 at 0 to 20 mM were used under the same conditions, with
similar results being obtained. The results described below
correspond to the experimental procedures using Ca2.
EDTA-treated dead C. neoformans cells had an average
capsule size smaller than that observed for untreated dead cells
(Fig. 4A). Divalent ions appeared to be relevant for capsule
assembly; differences in the average capsule size were observed
when C. neoformans was cultivated with various concentrations
of Ca2 (Fig. 4B). Yeast cells grown in the absence of divalent
ions had smaller capsules, although the concentration of GXM
was higher in supernatants than under any other culture con-
dition, a finding consistent with the reduced ability of C. neo-
formans to retain polysaccharides in the capsule. The addition
of increasing concentrations of Ca2 to the culture medium
resulted in augmented capsule expression associated with de-
creased levels of soluble GXM in fungal cultures. Very large
capsules were observed in yeast cells cultivated in the range of
0.01 to 0.3 mM Ca2. However, similarly to what has been
observed in the viscosity assays, high concentrations of CaCl2
caused a decrease in capsule sizes.
Although the results described above strongly support the
proposal that divalent cation-mediated aggregation of GXM is
involved in capsule enlargement, the possibility that the regu-
lation of gene expression and/or enzymatic activity was influ-
enced by capsule synthesis could not be excluded. We there-
fore examined the ability of poorly encapsulated dead cells of
C. neoformans to incorporate exogenously added GXM in the
presence of various Ca2 concentrations. To enhance the de-
tection of newly incorporated GXM chains, C. neoformans
cells were first irradiated to remove the existing external poly-
saccharide layers. GXM incorporation was then evaluated by
the quantitative reactivity of yeast cells with antibodies to the
polysaccharide (4). The binding of GXM to dead cells was
directly influenced by the availability of calcium (Fig. 4D). This
result indicates that, even in the absence of an active cellular
metabolism, GXM fibers can aggregate to the cell surface of C.
neoformans in a process modulated by divalent cations.
Comparison of GXM molecules obtained by ultrafiltration
and CTAB precipitation. The average molecular masses of
GXM obtained in the ultrafiltration cell or CTAB precipitation
(Table 1) were determined as described by McFadden and
coworkers (29). The molecular mass of the CTAB-derived
polysaccharide was comparable to that described previously for
FIG. 3. Influence of GlcA negative charges (A), a monovalent cation (B), a chelating agent (C), and a divalent cation (D) on the viscosity of
isolated GXM. (A) A reduction of around 95% of the content of GlcA in GXM was associated with a 90% decrease in polysaccharide viscosity
(P  0.05). Viscosity decreased in a dose-dependent way when Na (B) and EDTA (C) were used. Low Ca2 concentrations induced an increase
in polysaccharide viscosity, which was reversed with large amounts of the divalent ion (D). Results are means of three different measurements 

standard deviations.
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serotype D GXM (29). However, the average mass of the
polysaccharide purified by filtration was ninefold smaller. The
lower molecular mass observed for the filtered GXM was not
a consequence of mechanical shearing due to stirring, since the
CTAB-derived polysaccharide incubated for 24 h with stirring
had a molecular mass similar to that detected under regular
conditions. Other structural aspects were also determined
based on the light scattering data. Polysaccharide molecules
obtained by ultrafiltration had higher radius of gyration values.
This parameter was used in conjunction with Mw to calculate
the mass density of GXM from each preparation, revealing
that CTAB-derived polysaccharides were about 14-fold more
dense than filtered molecules. Interestingly, treatment of the
filtered polysaccharide with CTAB generated molecular
weight measurements similar to those obtained for the CTAB-
derived GXM, consistent with the notion that CTAB aggre-
gates GXM (S. Frases and A. Casadevall, unpublished results).
The data presented above suggested that GXM molecules
obtained from ultrafiltration cells are structurally different
from those purified by detergent precipitation. Since structural
features are directly related to antigenic properties, we evalu-
ated the reactivities of polysaccharides obtained by both meth-
ods with MAbs using an ELISA and a dot blotting assay. Three
different GXM-binding MAbs that bind different epitopes
were used for the antigenic analysis: 12A1, 18B7, and 21D2. As
shown in Fig. 5, GXM obtained by filtration and the polysac-
charide precipitated with CTAB were similarly recognized by
MAb 21D2. However, the filtered polysaccharide reacted more
strongly with MAbs 12A1 and 18B7 than CTAB-precipitated
GXM did, suggesting differences in epitope prevalence and/or
accessibility.
DISCUSSION
Synthesis and assembly of capsular components are key
events in the biology of C. neoformans. Several reports indicate
that capsule expression and/or enlargement in C. neoformans is
probably a multifactorial biological event controlled at differ-
ent levels (21, 22, 24, 28, 29, 37, 43–45). For instance, it has
been reported recently that CIR1, a gene identified as a Cryp-
tococcus iron regulator, controls the expression of all known
virulence factors, including capsule, melanin, and growth at
host temperature (22). In addition, capsule expression in C.
neoformans apparently requires the transport of the polysac-
charide to the extracellular environment in Golgi body-derived
vesicles that traverse the cell wall and, presumably, release
capsular components by a yet undetermined mechanism (37,
43). Capsule assembly at the extracellular face of the cell wall
involves the production of GXM fibers that include both at-
tached and released forms (29). The analysis of capsule growth
using complement as a marker of the old capsule revealed that
the old capsular material remains close to the cell wall during
capsular enlargement (44). The mechanisms by which GXM
fibers self-aggregate during apical capsule growth were still
unclear, however.
In the present work, we report the serendipitous observation
that the ultrafiltration and concentration of C. neoformans
supernatants resulted in the formation of a jellified polysac-
charide film that allows the use of a one-step procedure for the
isolation of capsular polysaccharide. Most importantly, this
finding also provided a new insight into the mechanisms of
capsule assembly that, together with well-described mecha-
nisms of GXM synthesis and secretion (21, 24, 28, 29, 37, 43)
FIG. 4. Influence of divalent ions on capsule expression. (A) Treatment of dead yeast cells with EDTA resulted in a significantly reduced
capsule size. (B) Increasing concentrations of Ca2 initially induce an enhancement in capsule expression, but excess cation concentrations cause
a decrease in capsule size. (C) Images of the most-representative capsule size-related events shown in panel B are depicted, with emphasis on the
very large capsules observed after fungal cultivation in the presence of 0.03 mM CaCl2. (D) The incubation of dead, poorly encapsulated C.
neoformans cells with GXM in the presence of various Ca2 concentrations results in polysaccharide incorporation, as determined by capture
ELISA (4).
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and other still unknown steps of polysaccharide self-associa-
tion, illustrate how the cryptococcal capsule enlarges.
Our finding that GXM coalesced into a polysaccharide film,
or gel, under conditions of flow-directed, increased concentra-
tion indicates that the molecule is capable of self-aggregation
and that this phenomenon is dependent on polysaccharide
concentration and perhaps directional flow. Both flow and
concentration are likely to be relevant parameters for C. neo-
formans capsule assembly, since capsule density varies as a
function of radial position and apical growth requires GXM
transport to the capsule edge from intracellular sites of bio-
synthesis. The fact that film formation was also observed when
supernatant fractions with molecular masses smaller than 100
kDa were filtered through 10-kDa membranes confirms the
high diversity in the molecular masses of GXM molecules (29)
and indicates that polysaccharide aggregation does not depend
on molecular weight.
To investigate mechanisms that could contribute to self-
aggregation, we studied the effect of divalent cations on GXM
viscosity. These ions are abundant in the culture medium
(Mg2) used in the present study, which led us to hypothesize
that cross-linking between GXM fibers would require a diva-
lent metal ion for two different GlcA residues. The efficacy of
this association would depend on water removal and increased
polysaccharide concentration, which should allow an efficient
interaction between GXM fibers and divalent ions at neutral
and alkaline pHs (pK of glucuronides, 3). Accordingly, the
carboxyl reduction of GXM film, as well as its treatment with
EDTA, monovalent ions, and excessive concentrations of
Ca2, reduced viscosity, supporting the role of divalent metals
on GXM aggregation. The direct interaction of polysaccharide
chains with divalent ions was also demonstrated, as inferred
from the reduced cellular charge of Mg2- and Ca2-treated
cryptococci and direct binding of the cations to GXM.
Early studies suggested that cultivation of C. neoformans in
high concentrations of NaCl (1 M) was associated with inhibi-
tion of capsule growth. Since this effect does not generally
apply to other solutes (20), we assumed that capsule growth
could be inhibited in the presence of Na by the univalent
neutralization of negatively charged GlcA residues. In this
case, divalent ions would be expected to positively modulate
capsule assembly in concentrations compatible with the 1:2
metal/GlcA ratio and reduce the capsule when provided in
excess. We therefore cultivated C. neoformans with various
concentrations of Ca2 and determined the capsule size. In
agreement with the viscosity assays, low concentrations of
Ca2 stimulated capsule growth, and higher concentrations
inhibited capsule assembly. At the higher Ca2 concentrations,
FIG. 5. Binding of MAbs to GXM obtained by CTAB precipitation (triangles) and ultrafiltration (squares) as determined by ELISA (A) and
dot blot analysis (B). Different MAbs were used for the reactions with the polysaccharides, including 18B7, 12A1, and 21D2. Polysaccharide
samples included GXM obtained by ultrafiltration and CTAB precipitation.
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saturation of GlcA residues by univalent calcium binding
would be expected to preclude intermolecular bridge forma-
tion. A model proposing the influence of divalent ions on the
growth of the cryptococcal capsule is shown in Fig. 6. This
model is supported by the fact that in plant cell walls, pectin
galacturonans can be cross-linked by the insertion of Ca2 ions
between the unesterified carboxyl groups of the galacturonosyl
residues (42).
Capsule expression is regulated during C. neoformans infec-
tion. For example, the capsule of yeast cells harvested from
infected tissues showed a greater matrix density than yeast cells
grown in vitro under capsule induction conditions (18). Cap-
sule expression varies according to the organ colonized by
cryptococci (17, 36), which may have a relationship with the
tissue concentration of divalent metals and perhaps pH, since
tissue pH would affect the ionization of GlcA carboxyl groups.
FIG. 6. Proposed model for GXM assembly on fungal cell surface. (A) GXM polymers are first covalently attached to the cell wall (not shown).
Extracellular GXM chains (Free GXM) are then layered by metal-mediated cross-linking. Each atom of Ca2 makes salt bridges between two
GlcA residues that are frequently from different polysaccharide fibers. (B) Binding of divalent ions to GlcA residues at a 1:2 ratio would support
capsule growth. (C) Excessive concentrations would neutralize GlcA negative charges, precluding capsule enlargement.
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This observation may be directly associated with the resistance
of C. neoformans to host defenses given that the primary func-
tion of the polysaccharide is to avoid phagocytosis (25, 30). On
the other hand, GXM release by C. neoformans could also
influence the availability of key regulators of physiological pro-
cesses such as Ca2 and Mg2. Since divalent metals can be
sequestered in the GXM fibers, their effective physiological
concentrations could be reduced in the presence of excess
polysaccharide.
Methods for the purification and structural analysis of GXM
have been intensively studied (1, 2, 6–8). Classical techniques
of polysaccharide purification include precipitation with etha-
nol and recovery of anionic structures by precipitation with
cationic detergents (8). It remains unclear, however, how the
reagents used in the different steps of GXM purification influ-
ence the polysaccharide structure. Furthermore, cationic de-
tergents are notoriously difficult to remove from GXM prep-
arations, and there is always the concern that such impurities
may contribute to the biological properties attributed to GXM.
Our findings revealed that the concentration of cryptococcal
supernatants in ultrafiltration cells resulted in the deposition of
a dense and viscous layer over the filtration disc. Spectrometric
and sugar compositional analyses revealed that this jellified
preparation consisted of essentially pure GXM. Such a fast and
efficient method of GXM isolation involves no denaturing
treatment or chemical modification of the polysaccharide. The
fact that GXM alone was found in the purified preparation
agrees with the fact that negative charges in polysaccharides
are determinants of molecular aggregation.
The molecular masses, lengths, and antigenicities of GXM
obtained by ultrafiltration and CTAB precipitation differed
considerably. Two of the MAbs used, 12A1 and 18B7, reacted
more intensely with the preparation obtained by concentration
in the ultrafiltration cell than with CTAB-derived GXM. In
contrast, the reactivities of both polysaccharide preparations
with MAb 21D2 were similar. We note with interest that our
NMR analysis of ultrafiltered GXM indicated the presence of
a mannosyl triad whose presence has been described previ-
ously only for a mutant strain of C. neoformans (2). This triad
is not one of the six classical triads described by Cherniak and
collaborators for serotype D GXM (7), and its presence is
consistent with structural differences that may translate into
antigenic differences. The molecular weight of EDTA-treated
polysaccharide was also analyzed, although no reduction in
molecular weight was observed (data not shown). Such infor-
mation, together with the fact that the removal of Ca2 by
EDTA treatment loosened some, but not all, polysaccharide
(Fig. 4A), indicates not only that the cation contributes to
capsule assembly but also that other molecular forces are op-
erative in holding the capsular polysaccharide together.
The finding that ultrafiltration-derived GXM had an average
mass that was ninefold smaller than that of CTAB-derived
GXM could have important biological implications. At the
very least, this observation suggests that there are many more
molecules of GXM on a mass basis than had been assumed.
Smaller-molecular-mass GXM can be expected to have differ-
ent pharmacokinetic and tissue penetration properties than
larger-molecular-mass GXM. The larger molecular mass of
CTAB-purified GXM presumably reflects the preferential pre-
cipitation of larger molecules or detergent-mediated aggrega-
tion. Given that most biological studies of the effects of GXM
on host immunity have been carried out with CTAB-purified
GXM, it is possible that these findings represent effects asso-
ciated only with the large GXM complexes. Hence, the method
described here provides the means to recover a fraction of
GXM that was previously unsuspected. The challenge ahead is
to understand how larger and smaller GXM fibrils are assem-
bled into a polysaccharide capsule. The observation that self-
aggregation of GXM fibers is mediated by divalent cations
suggests that much of the information required for capsule
assembly may be found within the structure of GXM itself,
which appears to have the capacity to self-assemble in complex
intermolecular lattices.
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